When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OMER - Omeros: The Commercial Prospects Remain Bright
Omeros Corporation
Investment Thesis Summary
On October 1, 2018, shares of Omeros Corporation (NASDAQ:OMER) dropped about 40% when the company announced positive phase 2 data for lead pipeline candidate narsoplimab . Investors were scared off by the fact that, following the initial 12-week course of treatment, there was no separation from placebo in terms of proteinuria reduction. However, the intent of the trial was not to show efficacy at week 12. Follow-up data showing proteinuria reduction at weeks 31-54 post-baseline demonstrate a clear separation from placebo. But the stock has yet to recover to its